Financial Projections

Jump to section

• Overview & contents
• i. Important Notice
• 1. Executive Summary
• 2. The South African Egg Market
• 3. Avian Influenza: The Risk That Defines This Business
• 4. SWOT and Competitive Position
• 5. The Five-Stage Roadmap
• 6. The Funding Ladder
• 7. Flock Performance
• 8. Feed Strategy
• 9. Point-of-Lay Pullet Sourcing
• 10. Biosecurity
• 11. Route to Market and Pricing
• 12. Operations and People
• 13. Regulation and Compliance
• 14. Unit Economics
• 15. Capital Expenditure
• 16. Financial Projections
• 17. Break-Even
• 18. Sensitivity and the Grant Question
• 19. Risk Management
• 20. Implementation Roadmap
• 21. Returns
• 22. Key Performance Indicators
• 23. Key Assumptions
• 24. Conclusion
• A. Appendix A: Consolidated Financial Summary
• B. Appendix B: Stage Capital Schedules
• C. Appendix C: Debt Schedules
• D. Appendix D: Risk Register
• E. Appendix E: Funding Application Checklist
• F. Appendix F: Glossary

16.1 Basis of preparation

• All amounts are in nominal South African rand. Revenue is built from average hens in lay, eggs per hen and a blended price per egg reflecting the channel mix in Section 11.
• Depreciation is charged on a straight-line basis across the asset classes funded by each stage: houses over twenty years, cages and equipment over ten, vehicles over five, solar over fifteen and the grading and milling plant over ten.
• Interest derives from the staged debt schedule in Appendix C, with a one-year capital moratorium on each tranche and a seven-year amortisation thereafter.
• Corporate income tax is applied at 27 per cent on taxable profit, with assessed losses carried forward subject to the section 20 limitation capping set-off at the higher of R1 million or 80 per cent of taxable income.
• The balance sheet is derived rather than plugged; shareholders’ funds roll forward from founder capital, grant capital recognised as it is received and retained earnings, and the closing cash position reconciles exactly to the cash flow statement in every year.

16.2 Projected income statement

Assessed losses of R912 000 accumulate across Stages 1 to 3. Year 4 taxable profit of R557 000 is fully offset, leaving R355 000 carried forward, which is applied in Year 5 against taxable profit of R3.37 million. Tax of R814 000 is therefore payable in Year 5 only, and the assessed loss is fully utilised.

16.3 Projected cash flow

Operating cash flow is negative in Stages 1 and 2, negative R230 000 and negative R241 000, and turns positive in Stage 3. Closing cash never falls below R70 000 because each stage raise is sized to carry the stage rather than merely to buy its assets, and it reaches R3.64 million by Year 5. That closing balance is what funds the restocking reserve in Section 3.1 and the R183 000 of capital not covered by external funding.

16.4 Projected balance sheet

Shareholders’ funds fall from R267 000 at the end of Stage 1 to R153 000 at the end of Stage 2 as the accumulated deficit builds, then recover to R6.30 million by Year 5 as grant capital is received and retained earnings accumulate. Total assets grow from R667 000 to R15.01 million. The balance sheet balances in every year and the closing cash line agrees exactly with the cash flow statement above.

16.5 Debt

Each tranche carries a one-year capital moratorium and a seven-year amortisation thereafter, at rates ranging from 6.5 per cent on the concessional blended finance and Agro-Energy facilities to 11 per cent on the early SEDFA facilities. EBITDA covers debt service 1.20 times at Stage 3, 3.06 times at Stage 4 and 5.42 times at Stage 5, comfortably clearing the 1.5 times Stage 5 gate condition.